BioProject,Run,EV_type,Source,disease,Disease_stage/treatment,Release_date,URL,EV isolated method,Project_Title,Project_Description
PRJEB15903,ERR1682041,sEV,Urine,Chronic kidney disease,Stage IV,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682042,sEV,Urine,Chronic kidney disease,Stage IV,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682043,sEV,Urine,Chronic kidney disease,Stage I,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682044,sEV,Urine,Chronic kidney disease,Stage I,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682045,sEV,Urine,Healthy donor,healthy donor,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682046,sEV,Urine,Chronic kidney disease,Stage IV,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682047,sEV,Urine,Chronic kidney disease,Stage III,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682048,sEV,Urine,Chronic kidney disease,Stage I,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682049,sEV,Urine,Chronic kidney disease,Stage IV,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682050,sEV,Urine,Chronic kidney disease,Stage III,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682051,sEV,Urine,Chronic kidney disease,Stage IV,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682052,sEV,Urine,Chronic kidney disease,Stage II,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682053,sEV,Urine,Chronic kidney disease,Stage II,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682054,sEV,Urine,Chronic kidney disease,Stage II,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682055,sEV,Urine,Chronic kidney disease,Stage II,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682056,sEV,Urine,Chronic kidney disease,Stage III,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682057,sEV,Urine,Healthy donor,healthy donor,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682058,sEV,Urine,Healthy donor,healthy donor,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682059,sEV,Urine,Healthy donor,healthy donor,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682060,sEV,Urine,Healthy donor,healthy donor,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682061,sEV,Urine,Healthy donor,healthy donor,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682062,sEV,Urine,Healthy donor,healthy donor,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682063,sEV,Urine,Healthy donor,healthy donor,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682064,sEV,Urine,Healthy donor,healthy donor,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
PRJEB15903,ERR1682065,sEV,Urine,Healthy donor,healthy donor,2016-12-01,https://pubmed.ncbi.nlm.nih.gov/27872161/,"RNA isolation of cell pellets and exosomes was carried out using the Tri-Reagent (Sigma) and miRcury RNA isolation kit-Biofluids (Exiqon), according to the manufacturer's instructions. Samples were dissolved in DEPC-treated water and stored at −80°C. Exosomes from supernatants were isolated as described earlier.",Identification of urinary exosomal non-coding RNAs as novel biomarkers in chronic kidney disease,"We aimed to identify urinary exosomal ncRNAs as novel biomarkers for diagnosis of Chronic Kidney Disease (CKD) for this, we examined 15 exosomal ncRNA profiles in urine samples from CKD patients from four different stages (I, II, III and IV) and compared them to 10 healthy controls. We identified a significant number of novel, differentially expressed ncRNAs in CKD patients compared to healthy, which might be employed as early diagnostic markers in CKD in the future."
